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Background—Delirium commonly occurs in patients with dementia. Though several tools for
detecting delirium exist, it is unclear which are valid in patients with delirium superimposed on
dementia.
Objectives—Identify valid tools to diagnose delirium superimposed on dementia
Design—We performed a systematic review of studies of delirium tools, which explicitly
included patients with dementia.
Setting—In-hospital patients
Participants—Studies were included if delirium assessment tools were validated against
standard criteria, and the presence of dementia was assessed according to standard criteria that
used validated instruments.
Measurements—PubMed, Embase, and Web of Science databases were searched for articles in
English published between January 1960 and January 2012.
Results—Nine studies fulfilled the selection criteria. Of the total of 1569 patients, 401 had
dementia, and 50 had delirium superimposed on dementia. Six delirium tools were evaluated. One
studyusing the Confusion Assessment Method (CAM) with 85% patients with dementia showed a
high specificity (96–100%) and moderate sensitivity (77%).Two intensive care unit studies that
used the CAM for the Intensive Care Unit (CAM-ICU) ICU reported 100% sensitivity and
specificity for delirium among 23 dementia patients. One study using electroencephalography
reported a sensitivity of 67% and a specificity of 91% among a population with 100% prevalence
of dementia. No studies examined potential effects of dementia severity or subtype upon
diagnostic accuracy.
Conclusions—The evidence base on tools for detection of delirium superimposed on dementia
is limited, although some existing tools show promise. Further studies of existing or refined tools
with larger samples and more detailed characterization of dementia are now required to address
the identification of delirium superimposed on dementia.
Keywords
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BACKGROUND
Delirium is a common geriatric syndrome characterized by acute and fluctuating disturbance
of consciousness, inattention, and deficits in arousal and cognition. Delirium that occurs in
patients with dementia is referred to as delirium superimposed on dementia (DSD). The
prevalence of DSD in community and hospital setting ranges from 22 to 89%,1 and is
greater than described in patients without dementia. By 2050, the number of individuals
aged 65 and older in the United States with Alzheimer’s disease, the most common form of
dementia, is projected to number between 11 and16 million.2 By extrapolation based on the
expected proportion of patients with dementia, up to 14 million patients will potentially
experience DSD, representing a massive health care challenge.3
DSD is associated with adverse outcomes that include accelerated cognitive and functional
decline, rehospitalization, institutionalization and mortality.4 Delirium has been proposed as
an additional vital sign5 and its presence is often the first sign of a change in clinical
condition, especially in older persons and those with dementia. For instance DSD might be
the harbinger of an undiscovered infection or a recent change of a medication with
psychoactive effects. Recognition of DSD should prompt an urgent and thorough clinical
evaluation of the patient and subsequent therapeutic actions.
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The diagnosis of DSD, however, is often challenging because signs of delirium might be
mistaken for the fluctuation of cognitive function, or psychological symptoms of patients
with dementia. Aside from the low levels of delirium detection in general6–8 practitioners
may not assess for DSD due to the perception that it cannot be readily distinguished from
dementia. There may also be a belief that current delirium detection instruments lack
adequate measurement properties in the context of dementia.
Although multiple tools have been developed and validated to diagnose delirium, it is
currently unclear which tools, if any, can be used in dementia patients and how accurately
such tools perform in this growing population. This is surprising, given that a substantial
number of patients with delirium also have dementia. A recent systematic review of
instruments to detect delirium9 reported detection instrument test characteristics in
hospitalized non-critically ill patients, but did not comment specifically on the performance
of these tools in patients with dementia.
The purpose of this systematic review is to summarize the available literature on the
performance characteristics of delirium screening instruments in samples explicitly
containing patients with dementia.
METHODS
Literature search strategy
This systematic review was registered on the Prospero systematic review website
(PROSPERO 2011: CRD42011001271). Searches of PUBMED, EMBASE, and WEB of
SCIENCE were conducted for articles published between January 1960 and January 22nd,
2012. The search terms were: delirium tools, delirium assessments combined with delirium,
confusion, acute confusional state, acute brain failure, acute confusion, dementia, cognitive
impairment, and Alzheimer’s disease. A complete search strategy can be found in Appendix
1,available in the online version.
Study selection and Data Extraction
We included validation studies which had evaluated delirium with tools using the Diagnostic
and Statistical Manual of Mental Disorders (DSM-IV)10or DSM-III11criteria as a gold
standard and included patients with dementia (diagnosed by neuropsychological battery or
using DSM-III, DSM-III-R, DSM-IV, DSM-IV-TR;10–12 or National Institute of
Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and
Related Disorders Association [NINCDS-ADRDA];13 or Blessed dementia rating scale
score [BDRS];14Informant Questionnaire on Cognitive Decline in the Elderly
[IQCODE];15or Clinical Dementia Rating Scale [CDR]16) or severe dementia (diagnosed by
neuropsychological battery using DSM-III, DSM-III-R, DSM-IV, DSM-IV-TR; or
NINCDS-ADRDA; or BDRS score ≥12; or CDR=3). Admissible study designs were
randomized controlled trials or observational studies with longitudinal or cross-sectional
designs.
We excluded studies that assessed solely alcohol-related delirium, had a study population
with age <18 years, did not apply DSM-IV or DSM-III criteria as a gold standard delirium
assessment, and did not assess dementia with validated measures, as described above. We
also excluded review articles, case series, duplicates, studies in which the index and
reference tests were administered by the same individual, and studies in which the index and
reference tests were administered on different days.
Each abstract was independently reviewed by 2 reviewers (A.M. and J.M.; E.V. and D.F;
G.B and J.C.J) to identify publications which met inclusion and exclusion criteria, and
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studies included and excluded were reported using the PRISMA systematic review
protocol.17 During the screening process, full texts were retrieved when information in the
abstract was not available or insufficient. In cases of disagreement between the 2 reviewers,
inclusion decisions were resolved by discussion and consensus with a third reviewer. This
procedure was required for 5 articles (5%) over the 100 selected.
Data were extracted independently by the reviewers cited above using the Standard for
Reporting of Diagnostic Accuracy (STARD)18and the Assessment of Methodological
Quality (QUADAS).19The following data were extracted if available: sensitivity, specificity
and likelihood ratios (LR) of the tools which included patients with dementia, sensitivity,
specificity, number of patients with dementia, number of patients with delirium and DSD,
presence of confounding psychiatric illnesses (i.e., depression), time interval between
assessment for delirium, definition of dementia, rater for delirium and dementia.
Assessment of Quality and Biases
Outcome reporting bias was evaluated comparing the methods section of each article with
the results. Unreported outcomes were those mentioned in the “Methods” section of the
study but not in the “Result” section. Publication bias was evaluated by reviewing reference
lists in each included study for abstracts, which had not been formally published in full
manuscript format. Quality of data reporting was evaluated with the Assessment of Quality
of Reporting (STARD criteria: score range 1–25 (higher=better).18 Quality of study
methodology was assessed with the Assessment of Methodological Quality (QUADAS
tool): score range 1–14 (higher=better).19
RESULTS
Search Results
A total of 10,273 citations were identified in the original literature search (Figure 1). An
additional 10 articles were identified through hand searching and 12 duplicates were
removed, resulting in 10,271 records that were screened for inclusion. 10,171 abstracts met
initial exclusion criteria and 100 full text articles were assessed for inclusion eligibility; 91of
those were excluded, with 9 included in the final review (Table 1).
Patient Characteristics
The age range of the study populations was 34 to 84 (mean 75.8, standard deviation (SD)
11.5). Patients were tested mainly in three clinical settings: inpatient geriatric/medical units,
stroke units, and the intensive care unit (ICU). Six studies were conducted in the USA, one
study in Germany, one in Finland, and one in the Czech Republic.20–27The overall sample
sizes ranged from 35 to 791 (mean 174, SD 243). Of the included studies only
one28specifically evaluated delirium in patients with dementia, whereas the others included
patients with the dementia as a subgroup of patients in the validation. The prevalence of
dementia in individual studies ranged from 12% to 100%. The number of patients with
identified DSD in individual studies ranged from 7 to 12; the total number of patients with
DSD from the whole population studied was 50. None reported severity or subtype of
dementia.
Delirium Screening Instruments
Six different tools (Confusion Assessment Method (CAM), Confusion Assessment Method
for the Intensive Care Unit (CAM-ICU), Cognitive Test for Delirium (CTD), Delirium
Rating Scale (DRS), electroencephalography (EEG), and the Short-Portable Mental Status
Questionnaire (SPMSQ)) were used to assess DSD.20–27
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Reporting Quality—89% of the studies reviewed achieved a “high” quality methodology
rating (QUADAS score ≥ 10) and 67% of the studies had a “high” quality data reporting
rating (STARD score ≥ 20) (Table 2). Importantly, 44% of the studies did not report the
time interval between the delirium assessment of the DSM rater and the index tool rater
(Table 2). Two studies20,21 allowed a maximum time of ≤ 4 hours, one study of ≤ 3
hours,25one study of ≤ 2 hours,27and one up to a maximum of 6 hours.24 The DSM raters for
delirium were neurologists, geriatricians, geriatric psychiatrists or experienced
neuropsychologists, providing a high standard of evaluation. Similarly, diagnosis of
probable dementia or dementia was performed by expert clinicians (i.e., neurologists,
psychiatrists or geriatric psychiatrists) (Table 1).
Screening for Delirium Superimposed on Dementia Test Characteristics—The
CAM was assessed in two studies including patients with dementia.24,25 It was originally24
developed and validated in a population of elderly patients admitted to a medical/geriatric
ward (N=56). Of these 12 (21%) had dementia and 9 of whom had DSD. Presence of
dementia was defined according to DSM-III-R criteria following an evaluation by a geriatric
psychiatrist. The sensitivity and specificity of the delirium tool in the entire sample ranged
from 94% (95% Confidence Interval (CI):68–100) to 100% (CI: 54–100) and from 90% (CI:
54–100) to 95% (CI: 73–100), respectively, but specific measures for those with dementia
were not reported. A subsequent validation study of a German translation of the CAM25
included a high percentage (85%) of patients with dementia (N=33). In the entire group
(N=39) of elderly patients admitted to an acute geriatric unit, the CAM had high specificity
(96% to 100%) and moderate sensitivity (77%)in delirium detection, with a likelihood ratio
for a positive test (LHR) of 19.25. The number of patients with DSD was 11 (28% of the
total sample; 33% of those with dementia), however, the test characteristics in this subgroup
were not reported. Diagnosis of dementia was obtained by a consensus between a geriatric
neuropsychiatrist and a geriatrician, blinded to the diagnosis of delirium, obtained through
the CAM evaluation. A structured interview of the family was performed by the psychiatrist
following the DSM-IV criteria. The final diagnosis of dementia was obtained combining this
information with the IQCODE, a surrogate interview administered to a close relative of each
patient by a psychologist. Additionally, no information was provided whether or not the
raters of the SPMSQ and reference standard were blind to the results of the other test.
Two validation studies of the CAM-ICU included a small number of patients with dementia,
among the 134 total patients20,21 admitted to an Intensive Care Unit. The sensitivity and
specificity in the entire sample were 98%–100% and 93%, respectively and a sensitivity of
100% (CI: 63–100) and specificity of 100% (CI: 3–100) for the diagnosis of DSD. The
presence of dementia was defined combining a geriatrician/geriatric psychiatrist evaluation
with the DSM-IV criteria or the BDRS performed by study nurses. According to these
methods 23 patients were classed as having dementia. The age range was 55 to 66 years.
Patients with suspected severe dementia were excluded. Though these studies specifically
report the sensitivity and specificity of the CAM-ICU in the subgroup of patients with
dementia, we could not retrieve the prevalence of DSD in one of the two validation studies.
The CAM-ICU was also applied27 in 129 patients admitted to a stroke unit (mean age 71.2 ±
11.5 years), of whom 31.8% had probable dementia defined according to the BDRS
performed by a neuropsychologist and 21 (38%) had DSD. As in the other two CAM-ICU
studies patients with severe dementia were excluded. In the entire sample the sensitivity
(76%) was moderate and specificity (98%) was high.
The quantitative EEG.28 showed high specificity (96–100%) and moderate sensitivity (77%)
for the diagnosis of DSD in 35 patients with dementia admitted to an acute geriatric ward.
Dementia was diagnosed according to the DSM-IV criteria by an expert panel (geriatric
specialist, neurologist, geriatric psychiatrist, psychologist and gerontologist), using the
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complete medical history, chart information, caregiver questionnaires, and
neuropsychological testing. It is unclear though how neuropsychological testing was used in
the context of delirium. Patients with severe dementia were excluded. The EEG was
performed by an expert neurophysiologist who was blinded to the clinical diagnosis of
delirium. The time between the clinical delirium assessment and the EEG evaluation was not
reported. The authors used two EEG techniques: resting EEG (rEEG) and quantitative EEG
(qEEG) with eyes open. With the rEEG, pathological results were frequent but were not
different between patients with DSD and patients with dementia alone. The rEEG provided
sensitivity of only 42% and specificity of 86% in detecting DSD. The quantitative EEG
(qEEG), with the presence of increased delta and reduced alpha2 activity during activation,
provided an increased sensitivity (67%) and specificity (91%) in detection of DSD.
The SPMSQ was evaluated22 in 282 elderly patients with a mean age of 75 (SD 7.2). Of
these, 34 (12%) had dementia previously documented and 7 (2%) experienced DSD. The
sensitivity and specificity of the tool in the entire population ranged from 7.3% to 98% and
from 82% to 100% respectively. The wide variation in the sensitivity is related to the
numbers of errors detected with the SPMSQ, which could be used as different cut-offs for
the diagnosis of delirium. The diagnosis of dementia was ascertained through a neurologist
interview according to DSM criteria. The quality of the data reporting was lower compared
to the other studies (STARD score, 11). In particular, the time between the SPMSQ
evaluation and the reference standard rater was not reported, creating potential bias in the
diagnosis of delirium given the fluctuation of this syndrome. Additionally, no information
was provided whether or not the readers of the index tests and reference standard were blind
to the results of the other test.
The CTD was23 tested in a group of 103 ICU patients (mean age 34.4–64.9), with a 25%
prevalence of dementia. The overall tool sensitivity (100%) and specificity (95%) were high.
The presence of dementia was assessed by a neuropsychologist with the DSM-III criteria
and with the MDRS. The CTD was found to have lower quality methodology compared to
the other tools (QUADAS score, 9). In particular, two features were found to be unclear: 1)
if the reference standard for delirium was independent of the index test and 2) if the patients
received the same reference standard regardless of the index result. As in the previous study
the time interval between the CTD evaluation and the DSM-rater evaluation was not
reported.
The DRS was evaluated26 in 791 geriatric patients admitted to an acute care psychogeriatric
unit (mean age 72.6), with a prevalence of dementia of 27% (N=197). The number of
patients with DSD was not reported, while the overall prevalence of delirium in the entire
population was 9% (N=70). The sensitivity of the tool (DRS score ≥10) in the entire
population was 94% and specificity 82%. As in the studies conducted by Erkinjuntti et al.22
and Hart23 time between the DRS evaluation and the DSM-rater evaluation was not
reported. The diagnosis of dementia was obtained through a consensus conference attended
by three to six geriatric psychiatrists according to the DSM-III criteria.
Documentation of depression—Information on the presence of depression was
reported only in 3 studies.23,24,26 The proportion of patients with depression ranged from
16%to 29%.23,24 Rosen24 reported a prevalence of major depression of 28%. No specific
subgroup analyses have been reported showing how the tools would perform differently in
diagnosing delirium in the presence of depression.
Overall the evidence of marked heterogeneity of the studies as reflected by the differing
populations and tests for delirium made a meta-analysis of this data not feasible.
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DISCUSSION
This is the first systematic review of the literature on the performance of existing tools for
delirium detection in patients with dementia. We found that the CAM and the derived CAM-
ICU both had preliminary data supporting their use in the general ward and ICU settings,
respectively. Nonetheless, the overall evidence base is small. Only 9 studies were of
sufficient quality to meet our final inclusion criteria. Although 1569 patients were assessed
in the included studies, only 50 patients had DSD as measured by validated methods. The
prevalence of DSD ranged from 2% to 38%. Interestingly, none of the studies reported any
effects of dementia severity or subtype. An expanded evidence base is required to draw
firmer conclusions about the performance characteristics of delirium measurement tools
among the growing and diverse populations of dementia patients.
On the basis of the available evidence, the CAM and the CAM-ICU have the most support
for the use in the diagnosis of DSD. Both the CAM studies included patients with dementia,
though neither specifically targeted a dementia subgroup. The Hestermann study25 provided
a potential indication of the use of the CAM in demented patients given the high prevalence
of dementia (85%). Here the CAM had high specificity for delirium but lower sensitivity.
The probability of missing the diagnosis was almost 30%, a level that is somewhat low
compared to delirium instruments that are used in a general population for routine clinical
use. In the CAM-ICU validation study20,21 patients with severe dementia were excluded and
no information was reported on the number of patients with probable mild and moderate
dementia, though the overall sensitivity and specificity of the tools in demented patients
were high. Serial EEGs have been proposed as a useful method in the diagnosis of
delirium.29 The study conducted by Thomas and colleagues28 produced mixed results: the
specificity of EEG was high, butsensitivity in the dementia population was only 67%. In
addition, the studies generalizability is limited by the exclusion of patients with severe
dementia. Thus, EEG might have a place in detecting DSD research studies, though further
replication in larger groups that include a greater variation in degrees of cognitive
impairments is needed.
This review has shown that the current evidence base is small and preliminary. We now
discuss some issues that future work might address.
The differences between delirium and dementia provide an obvious focus for the
development of scales with better ability to discriminate these conditions. One important
such area is how to most effectively capture information from caregivers in making the
diagnosis of DSD. Caregiver information is essential to ascertain if there has been an acute
decline (characteristic of delirium) but also to establish if there has also been a much longer
decline (characteristic of dementia). Caregivers can also clarify if fluctuations in the level of
alertness or of cognitive functions are different from baseline fluctuations. It may be that a
simple question asking about change is sufficient, but a more detailed dimension-based
checklist might have additional value. Another valuable discriminating feature is level of
consciousness. Alterations in level of consciousness are not always present in delirium, but
when present they are highly specific to this diagnosis.30 It may that this feature is
particularly valuable in situations where cognitive testing is hard to interpret due to the
presence of significant underlying impairments, or where such testing or even interviews are
impossible because of altered level of consciousness. Moreover, other non-cognitive
domains might be exploited in this way. For example, the Trunk Control Test –a measure of
the ability of a patient to control trunk position– was reported as a possible tool to
distinguish DSD from dementia.31 Better descriptions of motor disturbance may also be
useful, because compared to those with dementia, patients with may DSD have higher
perturbation in motor agitation and retardation.32
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Cognitive differences between delirium and dementia could also be examined in more depth.
Inattention is a core feature of delirium and thus differences in the severity and types of
attentional deficits that occur in delirium versus dementia may be useful in future diagnostic
tools. For example, sustained visual attention as assessed by an objective computerized
instrument (the “Edinburgh Delirium Test Box”) was reported to be highly impaired in
delirium but intact in Alzheimer’s dementia. Additionally, visual perception is impaired in
delirium but relatively preserved in most types of dementia.33,34 By contrast, tests of
memory are generally impaired in both delirium and Alzheimer’s dementia. Thus, objective
evaluation of specific deficits in sustained attention may be useful in differentiating
delirium-related inattention from typical dementia symptoms. The use of eye tracking
technology, as described by Exton and Leonard,35 might represent a further novel approach
to assess visual attention. Eye tracking might be used to specifically test visuospatial and
perceptual attention, working memory, motor agitation or retardation.35 These tests should
be then compared to existing delirium tools to identify which tools perform better in
dementia and in different stages of dementia. These types of tasks appear to have good or
excellent ability to discriminate between delirium and dementia. It is, however, unknown
how these tasks perform in different stages and types of dementia. Another important
knowledge gap is in understanding the impacts of the severity and subtype of dementia. This
matters because severe dementia is associated with neuropsychological deficits, including of
attentional functioning. Therefore some attentional tests might discriminate between mild
and/or moderate dementia and delirium, but not severe dementia. Subtypes of dementia
differ with respect to neuropsychological profile, fluctuations, and psychotic features.
Therefore, research taking account of these parameters of the dementia patients would be
informative. For instance, visual and visuospatial dysfunction, which has been studied in the
context of delirium, is a prominent feature of Dementia with Lewy Bodies but it is relatively
rare in AD,36 By contrast, patients with with fronto-temporal dementia have relatively
preserved visuospatial abilities.37
The variation in dementia diagnostic procedures may add interpretational biases, and lead to
populations with varying degrees of severity of dementia. A formal definition of dementia
obtained via neuropsychological testing, neuroimaging and biomarkers would be ideal for
improving comparisons across studies. As often happens in studies of acute hospitalized
inpatients it is cumbersome and often not practical to obtain a complete pre-hospital
evaluation. Although the included studies each used accepted methods to define the presence
of dementia, future studies should strive to apply similar methods of diagnosis to enable
better comparability of the research findings.
Finally, the overlap of delirium and depression might indeed interfere with the screening and
diagnosis of delirium, and needs to be further elucidated in future work. Leonard and
colleagues38 have previously highlighted how clinicians and researchers are limited in the
diagnosis of delirium due to difficulties in differentiating delirium from emotional
alterations such as depression. The current delirium tools do not include measures of mood/
affect, though anxiety and depressed mood are features of delirium.39 This gap might lead to
delirium and depression misclassification. Armstrong et al. found that 46% of patients
referred to a psychiatric liaison consultation were misdiagnosed and in 31% of the patients
depressive disorder was the most common incorrect diagnosis.40 An overlap of delirium,
depression and dementia would create additional challenges to the diagnosis of delirium. Of
the tools identified in this current systematic review as promising, only one study24 included
a measure of depression but given the small number of patients with depression a formal
analysis of the tool characteristics in patients with dementia and depression was not
performed. Future studies are also warranted to provide further insights on the role of the
overlap between delirium, depression and dementia for the diagnosis and screening of
delirium.
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Limitations of this systematic review include: (1) small number of identified studies; (2)
small numbers of patients with dementia and delirium superimposed on dementia included
in the studies; (3) lack of any studies done specifically to examine test performance in
dementia patients or evaluate in different dementia severity subgroups; (4) only studies
published in English were included; (5) studies evaluating solely alcohol-related delirium
were excluded. It is important to note that the majority of these limitations are a result of the
small number of studies of delirium diagnosis among dementia patients with a formal
diagnosis in the literature to date. Although these limitations may decrease the
generalizability and strength of the overall findings, they provide guidance on the future
directions that research in this domain should move to improve our ability to diagnose DSD.
Recent underlined research priorities41 in patients with advanced dementia, include the need
to develop “new advanced dementia-specific instruments for outcomes currently lacking
valid measures.” This systematic review provides the most up-to-date and comprehensive
information on test characteristics of existing tools for diagnosis of DSD, and highlights the
gaps in the literature. There are currently three tools with preliminary evidence in support of
their use in DSD: the CAM and the related CAM-ICU, and EEG, the latter of which lacks
widespread clinical applicability. Further work is now needed to assess how these tools
perform in the different stages and types of dementia, and studies with more DSD
participants are required. Additional tests such as objective assessments of attention, and
examination of the discriminatory value of level of consciousness are promising areas for
future study.
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Figure.
PRISMA flow diagram.
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